There are hundreds of publicly traded companies on various equity markets worldwide. Investors choose to put their ...

UK MHRA approves Vertex’s Alyftrek, a once-daily next-in-class CFTR modulator to treat cystic fibrosis: London Monday, March 10, 2025, 10:00 Hrs [IST] Vertex Pharmaceuticals, a ...

What's considered excellent revenue growth depends on the industry. With that context in mind, consider that Eli Lilly's ...

What's considered excellent revenue growth depends on the industry. With that context in mind, consider that Eli Lilly's ...

The agency approved it based on two Phase III studies showing the drug to be as effective as another combination therapy at improving lung function.

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today approved Alyftrek (triple combination medicine ...

Blue Square X  is excited to announce that Mark Templeton has joined the company as Director of Engineering, bringing over a decade of experience in the AV industry. With a background spanning ...

ACTFL is pleased to announce Hamilton actor Miguel Cervantes as the Opening Keynote Speaker, and Dr. Steve Boyes as the Closing Keynote Speaker, for the 2025 Annual Convention and World Languages ...

Vertex announced that the United Kingdom Medicines and Healthcare products Regulatory Agency has granted approval for ALYFTREK, a once-daily ...

In two randomised phase 3 studies involving 480 participants aged 12 years and over, ivacaftor/tezacaftor/vanzacaftor was ...

Vertex Pharmaceuticals operates in a profitable subsector and is poised for further success, says Dr Michael Tubbs ...

Congress did not reauthorize the rare pediatric disease priority review program at the end of 2024. Advocates say the ripple ...